Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Deferred Taxes (2016)

Historic Deferred Taxes for Aytu Biopharma (AYTU) over the last 2 years, with Q2 2016 value amounting to $8.7 million.

  • Aytu Biopharma's Deferred Taxes changed N/A to $8.7 million in Q2 2016 from the same period last year, while for Jun 2016 it was $8.7 million, marking a year-over-year change of. This contributed to the annual value of $7.9 million for FY2017, which is N/A changed from last year.
  • According to the latest figures from Q2 2016, Aytu Biopharma's Deferred Taxes is $8.7 million.
  • In the past 5 years, Aytu Biopharma's Deferred Taxes registered a high of $8.7 million during Q2 2016, and its lowest value of -$23909.0 during Q3 2014.